Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
58%
ALSO IN XPH
XPH
58
HOLDINGS
24%
ALSO IN PPH
SECTOR DRIFT (PPH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 20.9% | 2.1% | 2.1% |
|
ZOETIS INC | 2.6% | 2.0% | 2.0% |
|
PFIZER INC | 5.1% | 2.0% | 2.0% |
|
MERCK & CO. INC. | 13.2% | 2.0% | 2.0% |
|
JOHNSON & JOHNSON | 3.4% | 2.0% | 2.0% |
PPH Overweight Relative to XPH
|
ELI LILLY & CO | 18.8% |
|
MERCK & CO. INC. | 11.2% |
 |
NOVO-NORDISK A/S-SPONS ADR | 5.6% |
 |
TEVA PHARMACEUTICAL-SP ADR | 4.9% |
|
MCKESSON CORP | 4.7% |
|
CENCORA INC | 4.5% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 4.3% |
|
ABBVIE INC | 3.8% |
 |
NOVARTIS AG-ADR | 3.6% |
|
ASTRAZENECA PLC-SPONS ADR | 3.5% |
PPH Underweight Relative to XPH
|
VERADERMICS INC | -2.6% |
|
PACIRA PHARMACEUTICALS INC | -2.5% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.3% |
|
LIGAND PHARMACEUTICALS-CL B | -2.1% |
|
BIOSANTE PHARMACEUTICALS INC | -2.1% |
|
OMEROS CORP | -2.0% |
|
SUPERNUS PHARMACEUTICALS INC | -2.0% |
|
INNOVIVA, INC. | -2.0% |
 |
PERRIGO CO | -2.0% |
|
PRESTIGE BRANDS HOLDINGS INC | -2.0% |